Ego Pharmaceuticals continues to growSeptember 7, 2018
Ego Pharmaceuticals has climbed the rungs of the Top 500 Private Companies list, released today by the Australian Financial Review, to spot number 283. Impressive growth has seen Ego jump 21 spots since placing number 304 in 2017, and continuing its steady growth on the list over the last 4 years.
The list, published annually, considers company revenue over the latest 12-month accounting period and number of staff. Ego has 566 staff globally and posted a revenue growth of 17.7 per cent for the previous financial year.
Ego Pharmaceuticals is celebrating 65 years in 2018, being founded by husband and wife Gerald and Rae Oppenheim in 1953 in Melbourne and today the organisation stays true to its family heritage, with all products still being manufactured in Victoria, supporting Australian jobs.
Ego’s Managing Director and son of founder Gerald, Alan Oppenheim, said exports are now a huge focus for the organisation, with international sales making up 50% of the businesses revenue, and will continue to be a focus for years to come.
The company is committed to investing in the future growth of the company in Australia, having recently opened its new Global Headquarters in Dandenong South and with plans to build a second global manufacturing hub in Melbourne.